poisar

Stocks · News reference

'Trump Administration To End Medicare Drug Plan Subsidy; Program That Held Down Premiums Not Renewed For 2027, Resulting In Higher Costs For Some Seniors' - WSJ Exclusive

BenzingaJul 28, 2026, 8:02 PMBenzinga Newsdesk

https://www.wsj.com/health/healthcare/trump-administration-to-end-medicare-drug-plan-subsidy-76d255d1

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 28, 2026, 8:02 PM
Checked
Jul 28, 2026, 8:02 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchAug 27, 2026, 2:20 PMNa

    Can Cigna's Smart Coverage Help Close Health-Cost Gaps?

    Cigna Healthcare is introducing Smart Coverage, a new benefit option that automatically links medical claims with supplemental benefits to provide eligible members up to $7,000 for covered health events. The program launches January 1, 2027, for mid-sized employers and addresses a significant affordability gap, with nearly 60% of Americans unprepared for health costs. The initiative is designed to increase enrollment in high-deductible plans and boost supplemental product participation.

    Read original at zacks-investment-research
  2. The Motley FoolAug 27, 2026, 4:29 PMPatrick Sanders

    Billionaire Israel Englander's 2 Biggest Bets Are on the S&P 500, and He Just Bought More

    Billionaire investor Israel Englander's Millennium Management, which manages over $92 billion in assets, has made its two largest holdings S&P 500 index ETFs: iShares Core S&P 500 ETF (IVV) and SPDR S&P 500 ETF Trust (SPY). The fund recently purchased 1.5 million shares of IVV and 4.2 million shares of SPY in Q2, demonstrating that even sophisticated investors rely on low-cost index funds for diversification.

    Read original at the-motley-fool